Clinical Report: Navigating the Complexities of Lung Cancer Screening Criteria

Background

Lung cancer screening using low-dose computed tomography (LDCT) has been a major advancement in early cancer detection, significantly reducing mortality among high-risk individuals. However, many lung cancers occur in individuals who do not meet the stringent eligibility criteria. Understanding the epidemiology of lung cancer and the limitations of existing screening criteria is crucial.

Data Highlights

No numerical data available in the source material.

Key Findings

• 35.4% of lung cancer patients in South Korea would qualify for screening under the ACS guidelines.
• 49.6% of male lung cancer patients were eligible for screening compared to only 2.0% of female patients.
• Current South Korean criteria are more stringent than ACS guidelines, requiring 30 pack-years of smoking history.
• Many lung cancers arise in individuals outside current screening eligibility criteria.

Clinical Implications

Clinicians should be aware of the limitations of current guidelines and the disparities in screening eligibility based on sex and smoking history.

Conclusion

The complexities surrounding lung cancer screening criteria require careful consideration to ensure that at-risk populations are identified.

Related Resources & Content

1. The ASCO Post, August 2024 -- Can Alternative Criteria Help Identify Patients Who May Benefit From Lung Cancer Screening?
2. The ASCO Post, April 15, 2014 -- Decision Time for Lung Cancer Screening in High‑Risk Populations
3. Final Recommendation Statement: Lung Cancer: Screening | United States Preventive Services Taskforce
4. New Lung Cancer Screening Guideline Increases Eligibility | American Cancer Society
5. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025 - PubMed
6. The ASCO Post — Decision Time for Lung Cancer Screening in High‑Risk Populations
7. The ASCO Post — Lung Nodule Program May Help Detect Cancer in Patients Age-Ineligible for Lung Cancer Screening
8. Final Recommendation Statement: Lung Cancer: Screening | United States Preventive Services Taskforce
9. New Lung Cancer Screening Guideline Increases Eligibility | American Cancer Society
10. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025 - PubMed
11. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations - CHEST
12. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | New England Journal of Medicine
13. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial | New England Journal of Medicine
14. Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US | Lung Cancer | JAMA Oncology | JAMA Network
15. Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
16. Insufficient Evidence to Recommend Low-Dose CT Screening in Never Smokers Lung Cancer Screening: New Insights and Ongoing Debates | IASLC
17. LDCT screening for lung cancer in East Asian never-smokers: balancing benefits and overdiagnosis-related harms - PubMed
18. Overdiagnosis in low-dose CT lung cancer screening: A systematic review and meta-analysis of overall magnitude and subgroup variations - PubMed